Literature DB >> 6180022

Regulation of human natural killing. II. Protective effect of interferon on NK cells from suppression by PGE2.

K H Leung, H S Koren.   

Abstract

Activation of human natural killer (NK) cells in vitro with interferon (IFN) and poly I:C results in a partial loss of sensitivity of these cells to suppression by PGE2. The acquired resistance to suppression can be induced with the large granular lymphocytes (LGL) in the absence of monocytes. With K562, HSB, and CEM used as NK target cells, the IFN-induced resistance to suppression by PGE2 is observed with all three target cells. Furthermore, ADCC activity of IFN-activated cells against tumor (SB-TNP) and erythroid (CRC-TNP) target cells is also less susceptible to suppression by PGE2. The dual effect of IFN on NK cells is prompt; the augmentation of NK activity and the acquired resistance to suppression by PGE2 can be seen after 3 hr of treatment with IFN. Both of these characteristics seem to be quite stable for at least 24 hr. Spleen cells from mice (CBA, C3H, and BALB/c nude) treated in vivo with poly I:C also acquire partial resistance to suppression by PGE2. Our data therefore suggest that IFN-stimulated NK cells are protected from suppression by PGE2. Biologically, the IFN-induced protective effect may be beneficial to host resistance to neoplasia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180022

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Human lymphokine-activated killer (LAK) cells. I. Depletion of monocytes from peripheral blood mononuclear cells by L-phenylalanine methyl ester: an optimization of LAK cell generation at high cell density.

Authors:  K H Leung
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Effect of dietary polyunsaturated fat and 7,12-dimethylbenz(a)-anthracene on rat splenic natural killer cells and prostaglandin E synthesis.

Authors:  K H Leung; M M Ip
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Natural killer-like activity in human cultured lymphoid cells propagated in the presence of interleukin-2: acquired resistance to prostaglandin E2- or dexamethasone-mediated suppression.

Authors:  H Suzuki; N Yamashita; M Sato; M Iwata; M Maruyama; S Yano
Journal:  Experientia       Date:  1985-05-15

4.  Inducing a mode of NK-resistance to suppression by stress and surgery: a potential approach based on low dose of poly I-C to reduce postoperative cancer metastasis.

Authors:  Ella Rosenne; Guy Shakhar; Rivka Melamed; Yossi Schwartz; Anat Erdreich-Epstein; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2006-12-16       Impact factor: 7.217

Review 5.  Natural killer (NK) cells in antibacterial innate immunity: angels or devils?

Authors:  Fernando Souza-Fonseca-Guimaraes; Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

6.  Biosynthetic human interferon treatment of herpetic keratitis.

Authors:  G Smolin
Journal:  Trans Am Ophthalmol Soc       Date:  1983

7.  Human mononuclear phagocytes from different anatomical sites differ in their capacity to metabolize arachidonic acid.

Authors:  E Vicenzi; A Biondi; C Bordignon; A Rambaldi; M B Donati; A Mantovani
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

8.  The CySF-L2 factor from dialysable human leucocyte extract activates natural killer cytotoxicity by induction of interferon gamma.

Authors:  I Doelker; F A Anderer
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

9.  Human lymphokine-activated killer (LAK) cells: III. Effect of L-phenylalanine methyl ester on LAK cell activation from human peripheral blood mononuclear cells: possible protease involvement of monocytes, natural killer cells and LAK cells.

Authors:  K H Leung
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

10.  The nature of the natural killer (NK) cell of human intestinal mucosa and mesenteric lymph node.

Authors:  P R Gibson; D P Jewell
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.